Lung cancers are also rich in cancer-germline antigens [e.g., MAGE-A3 (22)], a number of differentiation antigens (e.g., CEA), and overexpressed shared antigens (e.g., survivin, WT1, MUC1), all being present in variable amounts across different patients. The gene discussed is CEACAM5; the disease is lung carcinoma.